discovered that CAFs‐derived exosomal miR‐3124‐5p conferred malignant development of NSCLC cells by targeting the TOLLIP/TLR4/MyD88/NF‐κB axis. This evidence concerns the gene TLR4 and non-small cell lung carcinoma.